FI55652C - Foerfarande foer framstaellning av 3-(4'-bromfenyl)-3-(3"-pyridyl)-1-dimetylaminopropan med antidepressiv verkan - Google Patents

Foerfarande foer framstaellning av 3-(4'-bromfenyl)-3-(3"-pyridyl)-1-dimetylaminopropan med antidepressiv verkan

Info

Publication number
FI55652C
FI55652C FI3386/73A FI338673A FI55652C FI 55652 C FI55652 C FI 55652C FI 3386/73 A FI3386/73 A FI 3386/73A FI 338673 A FI338673 A FI 338673A FI 55652 C FI55652 C FI 55652C
Authority
FI
Finland
Prior art keywords
framstating
dimethylaminopropan
antidepressive
bromophenyl
pyridyl
Prior art date
Application number
FI3386/73A
Other languages
English (en)
Other versions
FI55652B (fi
Inventor
Peder Bernhard Berntsson
Per Arvid Emil Carlsson
Hans Rudolf Corrodi
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of FI55652B publication Critical patent/FI55652B/fi
Publication of FI55652C publication Critical patent/FI55652C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI3386/73A 1972-11-16 1973-11-01 Foerfarande foer framstaellning av 3-(4'-bromfenyl)-3-(3"-pyridyl)-1-dimetylaminopropan med antidepressiv verkan FI55652C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7214872A SE373850B (fi) 1972-11-16 1972-11-16

Publications (2)

Publication Number Publication Date
FI55652B FI55652B (fi) 1979-05-31
FI55652C true FI55652C (fi) 1979-09-10

Family

ID=20299803

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3386/73A FI55652C (fi) 1972-11-16 1973-11-01 Foerfarande foer framstaellning av 3-(4'-bromfenyl)-3-(3"-pyridyl)-1-dimetylaminopropan med antidepressiv verkan

Country Status (17)

Country Link
JP (1) JPS5732058B2 (fi)
AR (1) AR204160A1 (fi)
AT (1) AT333278B (fi)
BE (1) BE806228A (fi)
CA (1) CA976553A (fi)
CH (1) CH586679A5 (fi)
DE (1) DE2356017A1 (fi)
DK (1) DK137898B (fi)
ES (1) ES420359A1 (fi)
FI (1) FI55652C (fi)
FR (1) FR2206942B1 (fi)
GB (1) GB1429068A (fi)
IE (1) IE38516B1 (fi)
NL (1) NL7315294A (fi)
SE (1) SE373850B (fi)
SU (1) SU482945A3 (fi)
ZA (1) ZA737973B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7909514L (sv) 1979-11-16 1981-05-17 Astra Laekemedel Ab Nya halofenyl-pyridyl-allylaminderivat

Also Published As

Publication number Publication date
DK137898C (fi) 1978-11-20
CA976553A (en) 1975-10-21
GB1429068A (en) 1976-03-24
FR2206942A1 (fi) 1974-06-14
IE38516B1 (en) 1978-03-29
FR2206942B1 (fi) 1977-01-28
DK137898B (da) 1978-05-29
AT333278B (de) 1976-11-10
CH586679A5 (fi) 1977-04-15
JPS5732058B2 (fi) 1982-07-08
AR204160A1 (es) 1975-11-28
AU6216573A (en) 1975-05-08
NL7315294A (fi) 1974-05-20
ATA938573A (de) 1976-03-15
BE806228A (fr) 1974-02-15
FI55652B (fi) 1979-05-31
DE2356017A1 (de) 1974-06-06
IE38516L (en) 1974-05-16
ES420359A1 (es) 1976-04-01
JPS49133379A (fi) 1974-12-21
ZA737973B (en) 1974-10-30
SE373850B (fi) 1975-02-17
SU482945A3 (ru) 1975-08-30

Similar Documents

Publication Publication Date Title
NO136839C (no) 1,2,4-triazolderivater med fungicid virkning
SE384505B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidinderivat
SE381047B (sv) Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat
SE393612B (sv) Forfarande for framstellning av vissa angivna benso-1,2,4-triazin-di-n-oxider
PH13020A (en) 3-(1h-tetrazol 5 yl)-chromone derivatives
FI54481B (fi) Foerfarande foer framstaellning av 5,8-dihydro-2-(1-piperazinyl)-5-oxo(2,3-d) pyrimidin-6-karboxylsyror med terapeutisk verkan
NO142710C (no) Fremgangsmaate til fremstilling av d-(-)-2-(p-hydroksyfenyl)-glycylklorid, hydroklorid
SE7600890L (sv) Forfarande for framstellning av 2-(6'-karbometoxihexyl)-2-cyklopenten-1-on
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE397085B (sv) Forfarande for framstellning av 2-(6'-karbalkoxihexyl)-4(r)-hydroxicyklopentan-1,3-dioner
SE394431B (sv) Forfarande for framstellning av 3-(p-klorfenyl)-2-(2-pyridyl)-propylaminer
SE7614320L (sv) Forfarande for framstellning av en ny heterocyklisk forening
SE445550B (sv) Forfarande for framstellning av fluormetyl-1,1,1,3,3,3-hexafluor-2-propyleter
SE416201B (sv) Foerfarande foer framstaellning av 1,4-bensodiazepinderivat
FI55652B (fi) Foerfarande foer framstaellning av 3-(4'-bromfenyl)-3-(3"-pyridyl)-1-dimetylaminopropan med antidepressiv verkan
SE417960B (sv) Forfarande for framstellning av sulfamoylfenyl-imidazolidinoner
SE380805B (sv) Forfarande for framstellning av oxazoler
SE398753B (sv) Forfarande for framstellning av 3',4'-didesoxitanamycin b
SE419980B (sv) Forfarande for framstellning av eventuellt substituerade 2-fenyl-bicyklo /2,2,2/okt-3-ylalkylaminer
SE393980B (sv) Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan
SE400472B (sv) Forfarande for framstellning av en antihypertensiv komposition
NO137073C (no) Fremgangsm}te for fremstilling av en innleggss}le
SE396389B (sv) Forfarande for framstellning av 2-karboxi-4-oxo-4h, 10h-(2)-bensopyrano-/4,3-g/-(1)-bensopyraner
SE426942B (sv) Forfarande for framstellning av foreningen 5-(5-(4-klorfenyl)-2-furanyl)-dihydro-2(3h)-furanon med antiinflammatorisk verkan
SE418084B (sv) Forfarande for framstellning av 1,2,4-bensotiadiazin-derivat